Page 172 - MEMORIA_SEHH-FEHH_2023

MEMORIA ANUAL 2023
GELTAMO
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
• Comparison Between aaIPI, LAB-PI, NCCN-IPI and GELTAMO-IPI to Predict Progno-
sis in Elderly Patients with Diffuse Large-B Cell Lymphoma who Undergo R-CHOP/R-
miniCHOP.
ICML 2023 (Lugano). Póster. Hematol Oncol. 2023;41:413-4. https://doi.org/10.1002/
hon.3164_304.
Martín-Moro F, Marquet-Palomanes J, Bento L, Díaz-López A, García-Vela JA, Sánchez-
Pina JM, Córdoba R, Salar A, Novelli S, Rodríguez-Salazar MJ, Lario-Arribas A, González
S, Del Campo R, Luzardo HD, García D, Abrisqueta P, García-Sancho AM, Sancho JM,
Gutiérrez A, López-Jiménez FJ, Bastos-Oreiro M.
• Relinf Registry-Based Analysis Shows Overall Survival Improvement with New Ther-
apies for Relapsed or Refractory Large B-Cell Lymphoma: A Study from the GELTAMO
Group.
Blood. 2023;142(Supplement 1):4870. doi: https://doi.org/10.1182/blood-2023-186594.
Abs. 4870. Session: 705. Cellular Immunotherapies: Late Phase and Commercially Avai-
lable Therapies: Poster III. (ASH).
Bastos-Oreiro M, Abrisqueta Costa P, Gutiérrez A, Jiménez Ubieto A, Pozas M, González
de Villambrosía S, Córdoba R, López García A, Pérez Ceballos E, Navarro B, Muntanola
A, Donato E, Díez-Baeza E, Escoda Teigell ML, Luzardo Henríquez HD, Peñarrubia-Ponce
M, García Belmonte D, Pardal E, Lozada C, López-Guillermo A, Martín García-Sancho A.
• Outcomes of CAR-T Cell Therapy for Large B Cell Lymphoma in Patients of 70 Years
and Older: Multicentric Experience on Behalf of GETH-TC/GELTAMO.
Blood. 2023;142(Supplement 1):4883. doi: https://doi.org/10.1182/blood-2023-185858.
Abs. 4883. Session: 705. Cellular Immunotherapies: Late Phase and Commercially Avai-
lable Therapies: Poster III (ASH).
Bailén R, Kwon M, Iacoboni G, Reguera JL, López Corral L, Hernani R, Ortiz-Maldonado
V, Guerreiro M, Caballero González AC, Guerra L, Sánchez Pina JM, Mussetti A, Sancho
JM, Bastos-Oreiro M, Catalá E, Delgado Serrano J, Luzardo Henríquez HD, Sanz Caballer
J, Calbacho M, Carpio C, Ribera JM, Torrent A, Sureda Balari AM, Briones J, Hernández
Boluda JC, Martínez-Cibrián N, Martín García-Sancho A, Barba P.
• Prognostic Factors and Treatment Strategy in Patients with Hodgkin Lymphoma
and HIV Infection Treated with ABVD and CART: A Retrospective Study from Spanish
Group GELTAMO.
Blood. 2023;142(Suppl. 1):4454. https://doi.org/10.1182/blood-2023-189756. Poster (ASH).
Huguet M, Méndez A, Sánchez-González B, Bastos-Oreiro M, García-Sanz R, Romero
S, Vidal-Manceñido MJ, Gutiérrez A, Villafuerte Gutiérrez P, García Noblejas A, Tapia G,
Sancho JM, Ribera JM, Navarro JT.
172